DK2047857T3 - Middel til injektionsformål omfattende antibiotika og opløsning til injektion omfattende midlet - Google Patents

Middel til injektionsformål omfattende antibiotika og opløsning til injektion omfattende midlet

Info

Publication number: DK2047857T3
Authority: DK; Denmark
Prior art keywords: injection; wap; solution; agent; composition
Prior art date: 2006-06-29

Application number

DK07767796.1T

Other languages

English (en)

Inventor

Hirofumi Nakajima

Haruhiko Machida

Original Assignee

Arigen Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-29

Filing date

2007-06-28

Publication date

2012-02-27

2007-06-28 Application filed by Arigen Pharmaceuticals Inc filed Critical Arigen Pharmaceuticals Inc

2012-02-27 Application granted granted Critical

2012-02-27 Publication of DK2047857T3 publication Critical patent/DK2047857T3/da

Links

238000002347 injection Methods 0.000 title abstract 3
239000007924 injection Substances 0.000 title abstract 3
239000000243 solution Substances 0.000 title abstract 3
239000003795 chemical substances by application Substances 0.000 title 2
239000003242 anti bacterial agent Substances 0.000 title 1
229940088710 antibiotic agent Drugs 0.000 title 1
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 3
229920000858 Cyclodextrin Polymers 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 2
108010002156 Depsipeptides Proteins 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
239000008121 dextrose Substances 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 abstract 1
238000001802 infusion Methods 0.000 abstract 1
238000001990 intravenous administration Methods 0.000 abstract 1
229910000403 monosodium phosphate Inorganic materials 0.000 abstract 1
235000019799 monosodium phosphate Nutrition 0.000 abstract 1
239000003002 pH adjusting agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical compound O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 abstract 1
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK07767796.1T 2006-06-29 2007-06-28 Middel til injektionsformål omfattende antibiotika og opløsning til injektion omfattende midlet DK2047857T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2006179778		2006-06-29
PCT/JP2007/063003 WO2008001849A1 (en)	2006-06-29	2007-06-28	Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent

Publications (1)

Publication Number	Publication Date
DK2047857T3 true DK2047857T3 (da)	2012-02-27

Family

ID=38845613

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07767796.1T DK2047857T3 (da)	2006-06-29	2007-06-28	Middel til injektionsformål omfattende antibiotika og opløsning til injektion omfattende midlet

Country Status (17)

Country	Link
US (1)	US7968588B2 (da)
EP (1)	EP2047857B1 (da)
JP (1)	JP5272126B2 (da)
KR (1)	KR101286038B1 (da)
CN (1)	CN101578103B (da)
AT (1)	ATE539761T1 (da)
AU (1)	AU2007266063B2 (da)
BR (1)	BRPI0713080A2 (da)
CA (1)	CA2656604C (da)
DK (1)	DK2047857T3 (da)
ES (1)	ES2378279T3 (da)
MX (1)	MX2009000155A (da)
PL (1)	PL2047857T3 (da)
PT (1)	PT2047857E (da)
RU (1)	RU2462261C2 (da)
SI (1)	SI2047857T1 (da)
WO (1)	WO2008001849A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101931880A (zh)	2009-06-19	2010-12-29	中兴通讯股份有限公司	一种多媒体广播组播业务动态复用的资源分配方法
JP5878302B2 (ja) *	2010-05-25	2016-03-08	株式会社ゲノム創薬研究所	新規環状ペプチド化合物とその製造方法及び感染症治療薬
JP5878303B2 (ja) *	2010-05-25	2016-03-08	株式会社ゲノム創薬研究所	抗生物質含有画分、その抗生物質及びその抗生物質の製造方法
MY200159A (en) *	2016-12-14	2023-12-09	Sk Biopharmaceuticals Co Ltd	Parenteral liquid preparation comprising carbamate compound
US10975121B2 (en)	2017-06-24	2021-04-13	Cytogel Pharma, Llc	Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
CN111683654A (zh) *	2017-11-30	2020-09-18	细胞凝胶制药有限责任公司	新型镇痛药物制剂及其用途
KR102434276B1 (ko)	2017-12-08	2022-08-18	엘지디스플레이 주식회사	표시장치
US12343374B2 (en)	2018-06-13	2025-07-01	Kyoto Biopharmaceuticals, Inc.	Enhancement of antibacterial actions of a depsipeptide antibiotic using synergistic amounts of boric acid

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3339235B2 (ja) *	1994-02-18	2002-10-28	日本メディカルリサーチ株式会社	抗生物質ｗａｐ−８２９４ａ、その製造法及び抗菌剤
KR100225601B1 (ko) *	1995-02-02	1999-10-15	오쿠다 기요아키	항생물질 wap-8294a와 이의 제조방법 및 항균조성물
JP4270588B2 (ja) *	1996-11-14	2009-06-03	康武日地	神経毒軽減麻酔剤
KR19980033113A (ko)	1996-10-25	1998-07-25	야스다케 히지	국소 마취제 수용액, 국소 마취제의 용해도를 개선시키는 방법, 신경독성이 감소된 국소 마취제 및 국소 마취제의 신경 독성을 감소시키는 방법
US6869927B1 (en) *	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
WO2000062793A2 (en)	1999-04-15	2000-10-26	Eli Lilly And Company	Pseudomycin antifungal compositions and methods for their use
AU5593200A (en) *	1999-06-02	2000-12-18	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
JP4074457B2 (ja) *	2001-12-20	2008-04-09	田辺三菱製薬株式会社	ヘパリン溶液入りプレフィルドシリンジ製剤およびその製造方法
EP1487540A2 (en) *	2002-03-20	2004-12-22	Pharmacia Corporation	Storage stable eplerenone formulation
AUPS188302A0 (en) *	2002-04-22	2002-05-30	Fujisawa Pharmaceutical Co., Ltd.	Pharmaceutical composition
JP2003321364A (ja) *	2002-05-07	2003-11-11	Eisai Co Ltd	シクロデキストリンにより可溶化及び安定化された抗腫瘍剤含有組成物
WO2003094889A1 (fr) *	2002-05-13	2003-11-20	Daiichi Pharmaceutical Co., Ltd.	Produit de lyophilisation
DE10228049A1 (de) *	2002-06-24	2004-01-15	Merck Patent Gmbh	Flüssige Zubereitung enthaltend Oligopeptide
US7361683B2 (en) *	2004-11-24	2008-04-22	Yung Shin Pharm. Ind., Co., Ltd	Paclitaxel aqueous injection solution and methods for preparing the same

2007
- 2007-06-28 RU RU2009102803/15A patent/RU2462261C2/ru not_active IP Right Cessation
- 2007-06-28 US US12/306,663 patent/US7968588B2/en not_active Expired - Fee Related
- 2007-06-28 DK DK07767796.1T patent/DK2047857T3/da active
- 2007-06-28 CN CN2007800322662A patent/CN101578103B/zh not_active Expired - Fee Related
- 2007-06-28 SI SI200730847T patent/SI2047857T1/sl unknown
- 2007-06-28 PT PT07767796T patent/PT2047857E/pt unknown
- 2007-06-28 KR KR1020097001274A patent/KR101286038B1/ko not_active Expired - Fee Related
- 2007-06-28 WO PCT/JP2007/063003 patent/WO2008001849A1/ja not_active Ceased
- 2007-06-28 CA CA2656604A patent/CA2656604C/en not_active Expired - Fee Related
- 2007-06-28 PL PL07767796T patent/PL2047857T3/pl unknown
- 2007-06-28 MX MX2009000155A patent/MX2009000155A/es active IP Right Grant
- 2007-06-28 JP JP2008522624A patent/JP5272126B2/ja not_active Expired - Fee Related
- 2007-06-28 AT AT07767796T patent/ATE539761T1/de active
- 2007-06-28 EP EP07767796A patent/EP2047857B1/en not_active Not-in-force
- 2007-06-28 BR BRPI0713080-5A patent/BRPI0713080A2/pt not_active Application Discontinuation
- 2007-06-28 ES ES07767796T patent/ES2378279T3/es active Active
- 2007-06-28 AU AU2007266063A patent/AU2007266063B2/en not_active Ceased

Also Published As

Publication number	Publication date
EP2047857A4 (en)	2010-05-26
AU2007266063B2 (en)	2011-09-08
RU2462261C2 (ru)	2012-09-27
BRPI0713080A2 (pt)	2012-10-09
SI2047857T1 (sl)	2012-03-30
ES2378279T3 (es)	2012-04-10
CN101578103A (zh)	2009-11-11
KR101286038B1 (ko)	2013-07-19
US20090258920A1 (en)	2009-10-15
RU2009102803A (ru)	2010-08-10
MX2009000155A (es)	2009-03-25
CA2656604A1 (en)	2008-01-03
AU2007266063A1 (en)	2008-01-03
ATE539761T1 (de)	2012-01-15
PL2047857T3 (pl)	2012-05-31
JP5272126B2 (ja)	2013-08-28
US7968588B2 (en)	2011-06-28
CN101578103B (zh)	2013-09-25
PT2047857E (pt)	2012-03-15
CA2656604C (en)	2014-01-07
EP2047857A1 (en)	2009-04-15
KR20090030317A (ko)	2009-03-24
JPWO2008001849A1 (ja)	2009-11-26
EP2047857B1 (en)	2012-01-04
WO2008001849A1 (en)	2008-01-03

Publication	Publication Date	Title
SI2047857T1 (sl)	2012-03-30	Sredstvo za injiciranje ki vsebuje antibiotik in raztopina za injiciranje ki vsebuje to sredstvo
ECSP077250A (es)	2007-03-29	Solución para infusión de dihidropteridinonas estabilizada para el almacenamiento
PT2038290E (pt)	2013-12-10	Moduladores de receptor do tipo toll 7
SG160364A1 (en)	2010-04-29	Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
DE602006014990D1 (de)	2010-07-29	Intranasale verabreichung von schnell wirkendem insulin
EA200971081A1 (ru)	2010-10-29	Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
WO2009097443A3 (en)	2009-12-10	Liquid formulations of compounds active at sulfonylurea receptors
MX2009000812A (es)	2009-07-10	Soluciones de metotrexato concentradas.
BRPI0714055B8 (pt)	2021-05-25	compostos moduladores de propriedades farmacocinéticas de terapêuticos, composições farmacêuticas que compreendem os referidos compostos e usos dos mesmo
MX338685B (es)	2016-04-26	Formulaciones de solucion intravenosa de posaconacol estabilizadas mediante beta-ciclodextrina sustituida.
DE602006012322D1 (de)	2010-04-01	Als androgen-rezeptor-modulatoren verwendbare tetrahydrocarbazol-derivate
AR037490A1 (es)	2004-11-17	Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
MX2009013835A (es)	2010-05-17	Forma de dosis estabilizada de picoplatino.
MXPA03011480A (es)	2004-03-18	Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
BRPI0418474A (pt)	2007-06-19	solução aquosa parenteral estável
DE60116483D1 (de)	2006-03-30	Gelartige pharmazeutische zusammensetzung zur subcutanen anwendung enthaltend bisphosphonsäuren oder deren salze
SA521430973B1 (ar)	2023-11-23	صيغ علاجية ثابتة في مذيبات قطبية غير بروتونية وطرق لتصنيعها
MX2020014262A (es)	2021-03-25	Composicion farmaceutica que comprende un agente basico poco soluble.
PE20011223A1 (es)	2001-12-20	Composicion farmaceutica que comprende pemetrexed y un antioxidante como monotioglicerol, l-cisteina y acido tioglicolico
EP1354602A4 (en)	2004-05-06	MEDICAL COMPOSITIONS WITH DIURETIC AGENT AND IMPROVING INSULIN RESISTANCE
ZA202210779B (en)	2025-02-26	Composition comprising trabectedin and an amino acid
TW200735864A (en)	2007-10-01	Immediate release pharmaceutical formulation
ECSP066477A (es)	2007-03-29	Composición farmacéutica que comprende ácido (2r)-2-propiloctanoico como un ingrediente activo
WO2007056263A3 (en)	2007-11-08	Methods of treating cancer with high potency lipid-based platinum compound formulations administered intravenously
MX2007015171A (es)	2008-04-22	Formulacion que comprende farnesil dibenzodiazepinona y un tensoactivo farmaceuticamente aceptable.